Telehealth industry leaders are putting pressure on the Drug Enforcement Administration to guide pharmacists on how to safely dispense controlled substances without limiting access for the drugs to patients who need them.
In a letter to the DEA released Wednesday, a consortium of online health-care companies, trade groups, and policy organizations urged the agency to provide explicit guidance informing pharmacies that the “geography of a prescriber in relation to the patient or the pharmacy should not be a ‘red flag’ when a prescription is a result of a telehealth visit.”
Currently, pharmacists who notice prescriptions filed by out-of-state telehealth providers ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.